North Carolina construction worker Derek Barnett, 55, lost more than 70 pounds on a unique nutrition and fitness journey after being diagnosed with liver cancer.

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Hepatocellular Carcinoma.

There’s a stigma surrounding liver cancer. Once you tell people you’ve got it, often you sense a slight judgment. “Oh”, you ...

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...

Advances in therapy are improving outcomes for patients, but the incidence and mortality rates for hepatocellular carcinoma ...

Scientists have revealed new insights into the origin of liver cancer and, more broadly, on the effects of a high-fat diet on our DNA.

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

Announcing a new publication for Acta Materia Medica journal. Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the ...

The following is a summary of “Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.